Asymmetry Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-215,985
| Closed | -$8.04M | – | 35 |
|
|
2021
Q3 | $8.04M | Buy |
+215,985
| New | +$8.04M | 4.83% | 10 |
|
|
2020
Q3 | – | Sell |
-73,708
| Closed | -$3.74M | – | 43 |
|
|
2020
Q2 | $3.74M | Sell |
73,708
-26,762
| -27% | -$1.36M | 2.87% | 15 |
|
|
2020
Q1 | $4.48M | Buy |
100,470
+45,062
| +81% | +$2.01M | 4.9% | 6 |
|
|
2019
Q4 | $2.66M | Sell |
55,408
-65,041
| -54% | -$3.12M | 4.77% | 7 |
|
|
2019
Q3 | $4.07M | Sell |
120,449
-160,093
| -57% | -$5.41M | 8.73% | 2 |
|
|
2019
Q2 | $12.6M | Buy |
280,542
+127,714
| +84% | +$5.75M | 6.84% | 6 |
|
|
2019
Q1 | $5.75M | Buy |
152,828
+42,034
| +38% | +$1.58M | 9.61% | 2 |
|
|
2018
Q4 | $3.8M | Sell |
110,794
-62,216
| -36% | -$2.14M | 10.5% | 3 |
|
|
2018
Q3 | $8.13M | Sell |
173,010
-32,021
| -16% | -$1.5M | 7.51% | 1 |
|
|
2018
Q2 | $6.92M | Sell |
205,031
-114,413
| -36% | -$3.86M | 6.8% | 3 |
|
|
2018
Q1 | $8.64M | Sell |
319,444
-232,114
| -42% | -$6.28M | 10.81% | 1 |
|
|
2017
Q4 | $9.2M | Buy |
551,558
+196,102
| +55% | +$3.27M | 12.49% | 1 |
|
|
2017
Q3 | $7.11M | Sell |
355,456
-172,659
| -33% | -$3.46M | 8.25% | 1 |
|
|
2017
Q2 | $9.68M | Sell |
528,115
-92,219
| -15% | -$1.69M | 11.48% | 1 |
|
|
2017
Q1 | $6.1M | Buy |
620,334
+135,755
| +28% | +$1.34M | 8.51% | 1 |
|
|
2016
Q4 | $5.29M | Sell |
484,579
-83,104
| -15% | -$907K | 9.83% | 1 |
|
|
2016
Q3 | $7.95M | Buy |
567,683
+261,033
| +85% | +$3.66M | 13.83% | 1 |
|
|
2016
Q2 | $2.15M | Buy |
+306,650
| New | +$2.15M | 3.94% | 11 |
|
|
2016
Q1 | – | Sell |
-237,100
| Closed | -$7.68M | – | 19 |
|
|
2015
Q4 | $7.68M | Buy |
+237,100
| New | +$7.68M | 11.62% | 1 |
|